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Methods: We prepared primary human subchondral osteoblasts using the
sclerotic medial portion of the tibial plateaus of OA patients undergoing
total knee arthroplasty, or from tibial plateaus of normal individuals at au-
topsy. The expression of Rspo-1 and -2 was evaluated by qRT-PCR and their
protein production by Western blot analysis. Wnt/β-catenin signaling was
evaluated using two approaches: 1) target gene expression was measured
using the TOPﬂash TCF/lef luciferase reporter assay, and 2) intracellular
signaling partners β-catenin, phospho β-catenin, GSK3β and phospho GSK3β
levels were evaluated by Western blot analysis. Mineralization in response
to Wnt3a in presence or not of Rspo-2 was evaluated by Alizarin red
staining.
Results: Rspo-1 expression was similar in normal and OA Ob. In contrast,
the expression of Rspo-2 was reduced in OA samples compared to normal.
Similarly, Western blot analysis revealed that Rspo-2 was reduced in OA
Ob compared to normal. TGF-β1 reduced Rspo-2 expression and produc-
tion whereas BMP-2 increased them. Wnt3a-dependent TOPﬂash TCF/lef
reporter assay was reduced in OA Ob compared to normal. Recombinant
human Rspo-2 alone failed to trigger Wnt signaling in OA Ob measured
using the TOPﬂash reporter assay however, it stimulated about two-fold
the Wnt3a-dependent response in these cells. Likewise, β-catenin levels
which increased in presence of Wnt3a alone were further increased by
Rspo-2 treatment. Rspo2 treatments also modulated the Wnt3a-dependent
phospho GSK3β response of OA Ob. Wnt3a alone increased the basal
mineralization of OA Ob and although Rspo-2 alone failed to modify the ab-
normal mineralization of OA Ob, it further increased the Wnt3a-dependent
mineralization of OA Ob.
Conclusions: These data demonstrate for the ﬁrst time that Rspo-2 is a new
key player in abnormal OA Ob function. Reduced Rspo-2 levels in OA Ob
are responsible, at least in part, for their reduced Wnt/β-catenin signaling
and abnormal mineralization. As Rspo-2 is a secreted soluble protein, this
could lead to potential new avenues of treatment of OA to correct their
abnormal bone phenotype and mineralization.
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Purpose: Chondrogenically differentiated human mesenchymal stromal
cells (hMSCs) are prone to undergo endochondral ossiﬁcation. Under nor-
mal circumstances, this process is limited to growth plate cartilage (GP)
but not articular cartilage (AC). The molecular mechanisms that prevent AC
from terminal differentiation and ossiﬁcation are largely unknown.
Our key objectives were i) to identify genetic markers that distinguish
AC from GP, and ii) to identify molecular mechanisms that prevent AC
from endochondral ossiﬁcation. We hypothesized that this information can
be utilized to optimize tissue engineering strategies to obtain AC from
differentiating hMSCs.
Methods: Gene expression proﬁles of healthy AC and GP from the same
patients were compared in a genome wide micro-array study. Protein
expression was investigated for three articular enriched genes using Im-
munohistochemistry on AC and GP. Recombinant proteins of the same three
articular enriched genes were added to chondrogenically differentiating
hMSCs to investigate their effect on hypertrophic differentiation.
Results: We identiﬁed differential expression of 2915 genes between GP
and AC, from which we generated a marker-set able to distinguish the two
hyaline cartilage subtypes. Furthermore, we showed that differentiating
MSCs acquire a genetic ﬁngerprint resembling GP, but not AC.
Interestingly, the three most differentially expressed genes, being enriched
in the AC, are Wnt- and BMP antagonists: FRZb, DKK1 and Gremlin1.
Immunohistochemistry demonstrated the presence of these antagonists
throughout the entire AC. In the GP their expression was mainly restricted
to the resting zone.
Chondrogenically differentiated hMSCs did not express the 3 antagonists
and underwent hypertrophic differentiation. Remarkably, the addition of
recombinant Grem1, FRZb or DKK1 did not affect chondrocyte differentia-
tion but prevented their hypertrophic differentiation.
Conclusions: Micro-array analysis has identiﬁed genetic ﬁngerprints highly
speciﬁc for the two types of hyaline cartilage, GP and AC, which can be
used to optimize tissue engineering strategies. We have identiﬁed the
Wnt- and BMP-antagonists, FRZb, DKK1 and Grem1 as speciﬁc markers
for AC. We show that these antagonists prevent hypertrophic chondrocyte
differentiation.
Our data suggest that Wnt- and BMP-antagonists play a prominent role in
establishing a joint micro-environment, which prevents AC from undergo-
ing endochondral ossiﬁcation.
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Purpose: CCAAT/enhancer-binding protein β (C/EBPβ) is a crucial tran-
scription factor for chondrocyte differentiation and cartilage degradation
in the process of endochondral ossiﬁcation during skeletal growth. Since
the endochondral ossiﬁcation process is also known to be important for
osteoarthritis (OA) development, this study examined the role of C/EBPβ in
OA development and explored the related molecular network.
Methods: We performed histological analyses of homozygous (-/-) or het-
erozygous (+/-) deﬁcient mice in comparison with the wild-type littermates.
An experimental OA model was created surgically by inducing instability
in the knee joints of 8-week-old mice, and OA severity was quantiﬁed by
the OARSI histopathology grade. Human joint cartilage was obtained as
surgical specimens of total knee arthroplasty. For functional analyses, we
created stable lines of human chondrogenic SW1353 cells with retroviral
overexpression of the genes, and evaluated the endogenous expression of
target genes by real-time RT-PCR. Screenings of upstream and downstream
signals were performed using SW1353 and human non-chondorogenic
HeLa cells transfected with luciferase-reporter constructs containing the
promoters. For comprehensive promoter analyses, we performed luciferase
assay, electrophoretic mobility shift assay (EMSA), and chromatin immuno-
precipitation assay involving sequential immunoprecipitation (ChIP-reIP)
using SW1353 and HeLa cells.
Results: The C/EBPβ expression increased with OA development in the
knee joint cartilages of the mouse experimental model and human sur-
gical specimens. This expression was co-localized with Runx2, another
key transcription factor for endochondral ossiﬁcation. Although C/EBPβ-/-
mice exhibited severe dwarﬁsm and Runx2-/- mice were embryonically
lethal, both C/EBPβ+/- mice and Runx2+/- mice grew normally under
physiological conditions. Under the OA induction, however, both +/- mice
showed resistance to joint cartilage degradation with decreased expres-
sions of endochondral ossiﬁcation markers like COL10A1, ADAMTS4, 5,
and MMP3, 9, 13, as compared to respective wild-type littermates. To
know the molecular interaction, we generated the compound heterozygous
deﬁcient (C/EBPβ+/-;Runx2+/-) mice. Although the C/EBPβ+/-;Runx2+/- mice
grew nornally, the resistance to OA development and decreases of the
endochondral ossiﬁcation markers were more enhanced than C/EBPβ+/-
or Runx2+/- littermates. Among the endochondral ossiﬁcation markers,
co-transfection of C/EBPβ and Runx2 most strongly enhanced promoter
activity and endogenous expression of MMP13. Analyses of the MMP13
promoter by luciferase assays identiﬁed the core responsive element as
being located between the -144 and -89 bp region containing a C/EBP-
binding motif (-103/-99) and a Runx-binding motif (-138/-132). Speciﬁc
and direct bindings of C/EBPβ and Runx2 proteins to respective motifs
were conﬁrmed by EMSA and ChIP-reIP assay. Interestingly, the binding of
C/EBPβ or Runx2 was blocked only when mutations were created in both
motifs, but not by mutagenesis in either motif alone, indicating that these
factors bind to respective motifs as a protein complex. We then explored
the upstream signal using theC/EBPβ promoter assay among transcription
factor families that are known to regulate chondrocyte differentiation, such
as Sox, Runx, other C/EBP, MEF2, SP/KLF, ATF, NF-κB, and hypoxia-inducible
factor (HIF); and identiﬁed HIF2A as the most potent transactivator of
C/EBPβ. Our further promoter analyses in the C/EBPβ promoter identiﬁed a
hypoxia-responsive element (HRE) motif (-69/-65) as the core responsive
region.
Conclusions: C/EBPβ plays a central role in cartilage degradation during OA
development by forming a molecular network with Runx2 as the co-factor,
MMP13 as the target, and HIF2A as the inducer. This signal on the C/EBPβ
axis may represent a therapeutic target for OA.
